Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of 12 Months Subcutaneous Tocilizumab in Rheumatoid Arthritis Phase IV Prospective Multicentrique Study
Phase of Trial: Phase IV
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms REPAIR
- 24 Mar 2017 Planned End Date changed from 1 May 2018 to 1 Jun 2019.
- 24 Mar 2017 Planned primary completion date changed from 1 May 2018 to 1 Jun 2019.
- 29 Sep 2016 Status changed from not yet recruiting to recruiting.